Immunovant, Inc.

IMVT

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001764013

SEC filings (opens in a new tab)

In the last 90 days, Immunovant, Inc. insiders filed 0 open-market purchases and 10 sales; 226 institutions reported holding it in 13F filings for Q2 2026, worth $4.25B in total; Greenlight Capital is the only superinvestor holding it.

Q4 2025 vs. Q3 2025

How the institutions holding Immunovant, Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025 All holders in Q3 2025

13F holders of IMVT: Q3 2025 compared with Q4 2025
Measure	Q3 2025	Of which not filed for Q4 2025	Q4 2025	Change
Holders	186	3	197	+14
Shares	95.2M	295.5K	108.6M	+13.8M (+14.5%)
Value	$1.53B	$4.76M	$2.76B	+$1.23B (+80.5%)

3 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (40)

Institutions that held Immunovant, Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to IMVT in Q4 2025
Institution	Shares	Value	% of portfolio
RTW Investments, LP	3,177,850	$80.8M	0.81%
TCG Crossover Management, LLC	1,660,933	$42.2M	1.40%
Soleus Capital Management, L.P.	1,110,000	$28.2M	1.20%
Jennison Associates LLC	700,464	$17.8M	0.01%
Candriam Luxembourg S.C.A.	680,372	$17.3M	0.09%
Trails Edge Capital Partners, LP	240,165	$6.10M	1.51%
ExodusPoint Capital Management, LP	126,621	$3.22M	0.04%
Nomura Asset Management International Inc.	122,100	$3.10M	0.00%
Trexquant Investment LP	114,995	$2.92M	0.03%
HRT Financial LP	84,840	$2.16M	0.01%
Blackstone Group Inc.	79,673	$2.03M	0.01%
Hennion & Walsh Asset Management, Inc.	71,705	$1.82M	0.06%
Amundi	67,404	$1.71M	0.00%
Alchemi Wealth, LLC	56,576	$1.44M	0.79%
Deeter Investments LLP	37,000	$940.5K	0.20%
Ishara Investments LP	30,000	$762.6K	0.89%
State of New Jersey Common Pension Fund D	23,799	$605.0K	0.00%
Y-Intercept (Hong Kong) Ltd	21,002	$533.9K	0.01%
PSP Research LLC	20,305	$516.2K	0.45%
VARCOV Co.	15,887	$403.8K	0.16%
Dark Forest Capital Management LP	14,064	$357.5K	0.02%
Arrowpoint Investment Partners (Singapore) Pte. Ltd.	13,714	$348.6K	0.05%
Allianz Asset Management GmbH	12,900	$327.9K	0.00%
SEI Investments Co	12,784	$325.0K	0.00%
Kestra Advisory Services, LLC	8,979	$228.2K	0.00%
Victory Capital Management Inc	8,537	$217.0K	0.00%
Quantbot Technologies LP	3,600	$91.5K	0.00%
Geneos Wealth Management Inc.	1,000	$25.4K	0.00%
Rockefeller Capital Management L.P.	669	$17.0K	0.00%
Kemnay Advisory Services Inc.	416	$10.6K	0.00%
Los Angeles Capital Management LLC	304	$7.54K	0.00%
Meeder Asset Management Inc	192	$4.88K	0.00%
Sankala Group LLC	150	$4.16K	0.00%
Huntington National Bank	116	$2.95K	0.00%
Basecamp Wealth Advisors LLC	31	$788	0.00%
Trust Co	21	$534	0.00%
Torren Management, LLC	21	$534	0.00%
SageView Advisory Group, LLC	15	$382	0.00%
Walleye Capital LLC	1	$25	0.00%
Dunhill Financial, LLC	1	$24	0.00%

Sold out (26)

Institutions that held Immunovant, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of IMVT in Q4 2025
Institution	Shares, Q3 2025	Value, Q3 2025
Balyasny Asset Management LLC	448,051	$7.22M
Marshall Wace, LLP	419,680	$6.77M
Jane Street Group, LLC	337,666	$5.44M
Sphera Funds Management Ltd.	256,743	$4.14M
Macquarie Group Ltd	122,100	$1.97M
Schonfeld Strategic Advisors LLC	115,750	$1.87M
Hudson Bay Capital Management LP	92,500	$1.49M
Rock Springs Capital Management LP	72,965	$1.18M
D. E. Shaw & Co., Inc.	56,700	$914.0K
Silverarc Capital Management, LLC	50,000	$806.0K
Voleon Capital Management LP	39,035	$629.2K
Capital Fund Management S.A.	35,128	$566.3K
Algert Global LLC	34,900	$562.6K
Voloridge Investment Management, LLC	31,950	$515.0K
Nomura Holdings Inc	30,000	$483.6K
Aigen Investment Management, LP	19,134	$308.4K
Fieldview Capital Management, LLC	17,577	$283.3K
Two Sigma Securities, LLC	17,281	$278.6K
Graham Capital Management, L.P.	15,119	$243.7K
Abc Arbitrage SA	14,639	$236.0K
Bridgefront Capital, LLC	13,654	$220.1K
Bayesian Capital Management, LP	12,976	$209.2K
Aster Capital Management (DIFC) Ltd	2,058	$33.2K
Halbert Hargrove Global Advisors, LLC	83	$1.34K
Advisory Services Network, LLC	9	$145
Cloud Capital Management, LLC	1	$0

Not filed for Q4 2025 yet (3)

Institutions that held Immunovant, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IMVT in Q3 2025 that haven't filed for Q4 2025
Institution	Shares, Q3 2025	Value, Q3 2025
Cubist Systematic Strategies, LLC	252,712	$4.07M
Point72 (DIFC) Ltd	27,698	$446.5K
Point72 Asia (Singapore) Pte. Ltd.	15,076	$243.0K